TreeWAS – Variant ID: rs4938303

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E78.0 Pure hypercholesterolaemia	0.000	0.000	1.000
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.000	0.353	0.647
E78.2 Mixed hyperlipidaemia	0.000	0.380	0.620
E78.3 Hyperchylomicronaemia	0.000	0.454	0.546
E78.1 Pure hyperglyceridaemia	0.000	0.470	0.530
E78.4 Other hyperlipidaemia	0.000	0.521	0.479
E78.6 Lipoprotein deficiency	0.000	0.555	0.445
E78.9 Disorder of lipoprotein metabolism, unspecified	0.000	0.580	0.420
E78.8 Other disorders of lipoprotein metabolism	0.000	0.691	0.309
E78.5 Hyperlipidaemia, unspecified	0.000	0.937	0.063
T43.0 Tricyclic and tetracyclic antidepressants	0.042	0.958	0.000
Z13.9 Special screening examination, unspecified	0.037	0.963	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.036	0.964	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.032	0.968	0.000
T43.9 Psychotropic drug, unspecified	0.029	0.971	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.029	0.971	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.028	0.971	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.027	0.973	0.000
T43.6 Psychostimulants with abuse potential	0.027	0.973	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.026	0.974	0.000
S51.0 Open wound of elbow	0.000	0.976	0.024
T43.2 Other and unspecified antidepressants	0.021	0.979	0.000
Z95.1 Presence of aortocoronary bypass graft	0.000	0.982	0.018
T36-T50 Poisoning by drugs, medicaments and biological substances	0.016	0.984	0.000
D75.9 Disease of blood and blood-forming organs, unspecified	0.016	0.984	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.015	0.985	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.015	0.985	0.000
T45.0 Antiallergic and antiemetic drugs	0.014	0.986	0.000
F20.9 Schizophrenia, unspecified	0.014	0.986	0.000
T42.4 Benzodiazepines	0.014	0.986	0.000
F20 Schizophrenia	0.013	0.987	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.013	0.987	0.000
T42.1 Iminostilbenes	0.013	0.987	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.013	0.987	0.000
M47.87 Other spondylosis (Lumbosacral region)	0.013	0.987	0.000
T45.5 Anticoagulants	0.012	0.988	0.000
C50.3 Lower-inner quadrant of breast	0.012	0.988	0.000
T42.3 Barbiturates	0.012	0.988	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.012	0.988	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.012	0.988	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.012	0.988	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.012	0.988	0.000
F32.3 Severe depressive episode with psychotic symptoms	0.012	0.988	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.012	0.988	0.000
F32 Depressive episode	0.012	0.988	0.000
F30-F39 Mood [affective] disorders	0.012	0.988	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.011	0.989	0.000
M47.89 Other spondylosis (Site unspecified)	0.011	0.989	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.011	0.989	0.000
T42.2 Succinimides and oxazolidinediones	0.011	0.989	0.000
F60-F69 Disorders of adult personality and behaviour	0.011	0.989	0.000
M47.8 Other spondylosis	0.011	0.989	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.011	0.989	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.011	0.989	0.000
F20.8 Other schizophrenia	0.011	0.989	0.000
F32.2 Severe depressive episode without psychotic symptoms	0.011	0.989	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.011	0.989	0.000
T45.8 Other primarily systemic and haematological agents	0.011	0.989	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.011	0.989	0.000
T45.6 Fibrinolysis-affecting drugs	0.011	0.989	0.000
T45.4 Iron and its compounds	0.011	0.989	0.000
T45.3 Enzymes, not elsewhere classified	0.011	0.989	0.000
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.000	0.989	0.011
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.011	0.989	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.011	0.989	0.000
F20.5 Residual schizophrenia	0.011	0.989	0.000
Chapter V Mental and behavioural disorders	0.011	0.989	0.000
F60 Specific personality disorders	0.011	0.989	0.000
M47.82 Other spondylosis (Cervical region)	0.011	0.989	0.000
F20.2 Catatonic schizophrenia	0.011	0.989	0.000
F60.9 Personality disorder, unspecified	0.011	0.989	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.010	0.989	0.000
M47.80 Other spondylosis (Multiple sites in spine)	0.010	0.990	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.010	0.990	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.010	0.990	0.000
T50.4 Drugs affecting uric acid metabolism	0.010	0.990	0.000
D75 Other diseases of blood and blood-forming organs	0.010	0.990	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.010	0.990	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.010	0.990	0.000
T42.0 Hydantoin derivatives	0.010	0.990	0.000
F61 Mixed and other personality disorders	0.010	0.990	0.000
F32.8 Other depressive episodes	0.010	0.990	0.000
F20.6 Simple schizophrenia	0.010	0.990	0.000
F20.4 Postschizophrenic depression	0.010	0.990	0.000
F20.3 Undifferentiated schizophrenia	0.010	0.990	0.000
F20.1 Hebephrenic schizophrenia	0.010	0.990	0.000
F00 Dementia in Alzheimer's disease	0.010	0.990	0.000
D75.2 Essential thrombocytosis	0.010	0.990	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.010	0.990	0.000
F20.0 Paranoid schizophrenia	0.010	0.990	0.000
F60.3 Emotionally unstable personality disorder	0.010	0.990	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.010	0.990	0.000
F33 Recurrent depressive disorder	0.010	0.990	0.000
T50.8 Diagnostic agents	0.010	0.990	0.000
F23 Acute and transient psychotic disorders	0.010	0.990	0.000
F34 Persistent mood [affective] disorders	0.009	0.990	0.000
T48.5 Anti-common-cold drugs	0.009	0.991	0.000
F69 Unspecified disorder of adult personality and behaviour	0.009	0.991	0.000
T38.1 Thyroid hormones and substitutes	0.009	0.991	0.000
F31 Bipolar affective disorder	0.009	0.991	0.000
T50.7 Analeptics and opioid receptor antagonists	0.009	0.991	0.000
T50.5 Appetite depressants	0.009	0.991	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.009	0.991	0.000
T50.0 Mineralocorticoids and their antagonists	0.009	0.991	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.009	0.991	0.000
T45.2 Vitamins, not elsewhere classified	0.009	0.991	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.009	0.991	0.000
F22 Persistent delusional disorders	0.009	0.991	0.000
F33.1 Recurrent depressive disorder, current episode moderate	0.009	0.991	0.000
F32.1 Moderate depressive episode	0.009	0.991	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.009	0.991	0.000
T48.4 Expectorants	0.009	0.991	0.000
T48.3 Antitussives	0.009	0.991	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.009	0.991	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.009	0.991	0.000
T48.0 Oxytocic drugs	0.009	0.991	0.000
D75.1 Secondary polycythaemia	0.009	0.991	0.000
T36 Poisoning by systemic antibiotics	0.009	0.991	0.000
T38.0 Glucocorticoids and synthetic analogues	0.009	0.991	0.000
T47.0 Histamine H(2)-receptor antagonists	0.009	0.991	0.000
T50.1 Loop [high-ceiling] diuretics	0.009	0.991	0.000
T38.9 Other and unspecified hormone antagonists	0.009	0.991	0.000
T38.7 Androgens and anabolic congeners	0.009	0.991	0.000
T38.5 Other oestrogens and progestogens	0.009	0.991	0.000
T38.4 Oral contraceptives	0.009	0.991	0.000
T38.2 Antithyroid drugs	0.009	0.991	0.000
I71 Aortic aneurysm and dissection	0.000	0.991	0.009
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.009	0.991	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.009	0.991	0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.009	0.991	0.000
F28 Other nonorganic psychotic disorders	0.008	0.991	0.000
F24 Induced delusional disorder	0.008	0.991	0.000
F21 Schizotypal disorder	0.008	0.991	0.000
F80-F89 Disorders of psychological development	0.009	0.991	0.000
M47.83 Other spondylosis (Cervicothoracic region)	0.008	0.991	0.000
F62 Enduring personality changes, not attributable to brain damage and disease	0.008	0.991	0.000
F25 Schizoaffective disorders	0.009	0.991	0.000
R82.9 Other and unspecified abnormal finding in urine	0.009	0.991	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.008	0.992	0.000
F30 Manic episode	0.008	0.992	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.008	0.992	0.000
F65 Disorders of sexual preference	0.008	0.992	0.000
F63 Habit and impulse disorders	0.008	0.992	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.008	0.992	0.000
M47.81 Other spondylosis (Occipito-atlanto-axial region)	0.008	0.992	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.008	0.992	0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.008	0.992	0.000
F64 Gender identity disorders	0.008	0.992	0.000
T41.5 Therapeutic gases	0.008	0.992	0.000
T41.4 Anaesthetic, unspecified	0.008	0.992	0.000
T41.3 Local anaesthetics	0.008	0.992	0.000
T41.1 Intravenous anaesthetics	0.008	0.992	0.000
T41.0 Inhaled anaesthetics	0.008	0.992	0.000
F38 Other mood [affective] disorders	0.008	0.992	0.000
T49.9 Topical agent, unspecified	0.008	0.992	0.000
T49.8 Other topical agents	0.008	0.992	0.000
T49.7 Dental drugs, topically applied	0.008	0.992	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.008	0.992	0.000
T49.5 Ophthalmological drugs and preparations	0.008	0.992	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.008	0.992	0.000
T49.3 Emollients, demulcents and protectants	0.008	0.992	0.000
T49.2 Local astringents and local detergents	0.008	0.992	0.000
T49.1 Antipruritics	0.008	0.992	0.000
F23.9 Acute and transient psychotic disorder, unspecified	0.008	0.992	0.000
I71.3 Abdominal aortic aneurysm, ruptured	0.000	0.992	0.008
F34.1 Dysthymia	0.008	0.992	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.008	0.992	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.008	0.992	0.000
R47.8 Other and unspecified speech disturbances	0.000	0.992	0.008
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.008	0.992	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.008	0.992	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.008	0.992	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.008	0.992	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.008	0.992	0.000
T44.0 Anticholinesterase agents	0.008	0.992	0.000
F68 Other disorders of adult personality and behaviour	0.008	0.992	0.000
T41.2 Other and unspecified general anaesthetics	0.008	0.992	0.000
M47.85 Other spondylosis (Thoracolumbar region)	0.008	0.992	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.008	0.992	0.000
F60.4 Histrionic personality disorder	0.008	0.992	0.000
F60.1 Schizoid personality disorder	0.008	0.992	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.008	0.992	0.000
T47.6 Antidiarrhoeal drugs	0.008	0.992	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.008	0.992	0.000
T37.5 Antiviral drugs	0.008	0.992	0.000
T37.4 Anthelminthics	0.008	0.992	0.000
T37.3 Other antiprotozoal drugs	0.008	0.992	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.008	0.992	0.000
T37.1 Antimycobacterial drugs	0.008	0.992	0.000
T37.0 Sulphonamides	0.008	0.992	0.000
T46.1 Calcium-channel blockers	0.008	0.992	0.000
F00.0 Dementia in Alzheimer's disease with early onset	0.008	0.992	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.008	0.992	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.008	0.992	0.000
M47.88 Other spondylosis (Sacral and sacrococcygeal region)	0.008	0.992	0.000
F99-F99 Unspecified mental disorder	0.008	0.992	0.000
F31.8 Other bipolar affective disorders	0.008	0.992	0.000
F60.2 Dissocial personality disorder	0.008	0.992	0.000
F60.7 Dependent personality disorder	0.008	0.992	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.008	0.992	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.008	0.992	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.008	0.992	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.008	0.992	0.000
F23.8 Other acute and transient psychotic disorders	0.008	0.992	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.007	0.992	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.007	0.992	0.000
T47.7 Emetics	0.007	0.992	0.000
T47.5 Digestants	0.007	0.992	0.000
T47.3 Saline and osmotic laxatives	0.007	0.992	0.000
F33.8 Other recurrent depressive disorders	0.008	0.992	0.000
F60.8 Other specific personality disorders	0.007	0.992	0.000
F70-F79 Mental retardation	0.007	0.992	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.007	0.992	0.000
M47.84 Other spondylosis (Thoracic region)	0.007	0.993	0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.000	0.993	0.007
F22.0 Delusional disorder	0.007	0.993	0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.007	0.993	0.000
T47.4 Other laxatives	0.007	0.993	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.007	0.993	0.000
T46.7 Peripheral vasodilators	0.007	0.993	0.000
F60.6 Anxious [avoidant] personality disorder	0.007	0.993	0.000
F25.2 Schizoaffective disorder, mixed type	0.007	0.993	0.000
F95 Tic disorders	0.007	0.993	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.007	0.993	0.000
F07.2 Postconcussional syndrome	0.007	0.993	0.000
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture	0.000	0.993	0.007
F09 Unspecified organic or symptomatic mental disorder	0.007	0.993	0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.007	0.993	0.000
F39 Unspecified mood [affective] disorder	0.007	0.993	0.000
F23.2 Acute schizophrenia-like psychotic disorder	0.007	0.993	0.000
F84 Pervasive developmental disorders	0.007	0.993	0.000
F34.9 Persistent mood [affective] disorder, unspecified	0.007	0.993	0.000
F34.8 Other persistent mood [affective] disorders	0.007	0.993	0.000
F60.0 Paranoid personality disorder	0.007	0.993	0.000
F60.5 Anankastic personality disorder	0.007	0.993	0.000
T47.2 Stimulant laxatives	0.007	0.993	0.000
M70.22 Olecranon bursitis-Upper arm	0.007	0.993	0.000
F00.1 Dementia in Alzheimer's disease with late onset	0.007	0.993	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.007	0.993	0.000
F34.0 Cyclothymia	0.007	0.993	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.007	0.993	0.000
F32.0 Mild depressive episode	0.007	0.993	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.007	0.993	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.007	0.993	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.007	0.993	0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.007	0.993	0.000
F02 Dementia in other diseases classified elsewhere	0.007	0.993	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.007	0.993	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.007	0.993	0.000
F22.8 Other persistent delusional disorders	0.007	0.993	0.000
T36.4 Tetracyclines	0.006	0.993	0.000
F03 Unspecified dementia	0.007	0.993	0.000
K29.1 Other acute gastritis	0.007	0.993	0.000
F31.7 Bipolar affective disorder, currently in remission	0.007	0.993	0.000
T36.9 Systemic antibiotic, unspecified	0.006	0.993	0.000
T36.7 Antifungal antibiotics, systemically used	0.006	0.993	0.000
T36.6 Rifamycins	0.006	0.993	0.000
T36.5 Aminoglycosides	0.006	0.993	0.000
T36.2 Chloramphenicol group	0.006	0.993	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.006	0.993	0.000
F62.9 Enduring personality change, unspecified	0.006	0.993	0.000
F05 Delirium, not induced by alcohol and other psychoactive substances	0.007	0.993	0.000
E70-E90 Metabolic disorders	0.000	0.993	0.007
F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction	0.006	0.993	0.000
F80 Specific developmental disorders of speech and language	0.006	0.993	0.000
T36.8 Other systemic antibiotics	0.006	0.993	0.000
I71.8 Aortic aneurysm of unspecified site, ruptured	0.000	0.993	0.006
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.000	0.993	0.006
T40.5 Cocaine	0.006	0.993	0.000
M79.00 Rheumatism, unspecified (Multiple sites)	0.007	0.993	0.000
F22.9 Persistent delusional disorder, unspecified	0.006	0.993	0.000
F25.0 Schizoaffective disorder, manic type	0.006	0.993	0.000
F94 Disorders of social functioning with onset specific to childhood and adolescence	0.006	0.993	0.000
F93 Emotional disorders with onset specific to childhood	0.006	0.993	0.000
F92 Mixed disorders of conduct and emotions	0.006	0.993	0.000
F91 Conduct disorders	0.006	0.993	0.000
F90 Hyperkinetic disorders	0.006	0.993	0.000
F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.006	0.993	0.000
F89 Unspecified disorder of psychological development	0.006	0.994	0.000
F88 Other disorders of psychological development	0.006	0.994	0.000
F83 Mixed specific developmental disorders	0.006	0.994	0.000
F82 Specific developmental disorder of motor function	0.006	0.994	0.000
F30.9 Manic episode, unspecified	0.006	0.994	0.000
F62.8 Other enduring personality changes	0.006	0.994	0.000
F62.1 Enduring personality change after psychiatric illness	0.006	0.994	0.000
F62.0 Enduring personality change after catastrophic experience	0.006	0.994	0.000
F25.8 Other schizoaffective disorders	0.006	0.994	0.000
T36.3 Macrolides	0.006	0.994	0.000
T40.1 Heroin	0.006	0.994	0.000
D75.8 Other specified diseases of blood and blood-forming organs	0.006	0.994	0.000
F01 Vascular dementia	0.006	0.994	0.000
M79.0 Rheumatism, unspecified	0.006	0.994	0.000
I71.1 Thoracic aortic aneurysm, ruptured	0.000	0.994	0.006
I61 Intracerebral haemorrhage	0.006	0.994	0.000
D75.0 Familial erythrocytosis	0.006	0.994	0.000
F30.8 Other manic episodes	0.006	0.994	0.000
F63.9 Habit and impulse disorder, unspecified	0.006	0.994	0.000
F63.8 Other habit and impulse disorders	0.006	0.994	0.000
F63.3 Trichotillomania	0.006	0.994	0.000
F63.2 Pathological stealing [kleptomania]	0.006	0.994	0.000
F63.1 Pathological fire-setting [pyromania]	0.006	0.994	0.000
F63.0 Pathological gambling	0.006	0.994	0.000
F65.9 Disorder of sexual preference, unspecified	0.006	0.994	0.000
F65.8 Other disorders of sexual preference	0.006	0.994	0.000
F65.6 Multiple disorders of sexual preference	0.006	0.994	0.000
F65.5 Sadomasochism	0.006	0.994	0.000
F65.4 Paedophilia	0.006	0.994	0.000
F65.3 Voyeurism	0.006	0.994	0.000
F65.2 Exhibitionism	0.006	0.994	0.000
F65.1 Fetishistic transvestism	0.006	0.994	0.000
F65.0 Fetishism	0.006	0.994	0.000
F66.9 Psychosexual development disorder, unspecified	0.006	0.994	0.000
F66.8 Other psychosexual development disorders	0.006	0.994	0.000
F66.2 Sexual relationship disorder	0.006	0.994	0.000
F66.1 Egodystonic sexual orientation	0.006	0.994	0.000
F66.0 Sexual maturation disorder	0.006	0.994	0.000
F81 Specific developmental disorders of scholastic skills	0.006	0.994	0.000
F95.2 Combined vocal and multiple motor tic disorder [de la Tourette]	0.006	0.994	0.000
F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction	0.006	0.994	0.000
F07.1 Postencephalitic syndrome	0.006	0.994	0.000
F30.1 Mania without psychotic symptoms	0.006	0.994	0.000
F64.9 Gender identity disorder, unspecified	0.006	0.994	0.000
F64.8 Other gender identity disorders	0.006	0.994	0.000
F64.2 Gender identity disorder of childhood	0.006	0.994	0.000
F64.1 Dual-role transvestism	0.006	0.994	0.000
F38.8 Other specified mood [affective] disorders	0.006	0.994	0.000
F38.1 Other recurrent mood [affective] disorders	0.006	0.994	0.000
F30.0 Hypomania	0.006	0.994	0.000
F64.0 Transsexualism	0.006	0.994	0.000
M70.65 Trochanteric bursitis-Pelvic/Thigh	0.006	0.994	0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.006	0.994	0.000
S51 Open wound of forearm	0.000	0.994	0.006
F07.0 Organic personality disorder	0.006	0.994	0.000
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.006	0.994	0.000
F68.8 Other specified disorders of adult personality and behaviour	0.006	0.994	0.000
F68.0 Elaboration of physical symptoms for psychological reasons	0.006	0.994	0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.006	0.994	0.000
F25.1 Schizoaffective disorder, depressive type	0.006	0.994	0.000
F30.2 Mania with psychotic symptoms	0.006	0.994	0.000
F38.0 Other single mood [affective] disorders	0.006	0.994	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.006	0.994	0.000
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.000	0.994	0.006
F29 Unspecified nonorganic psychosis	0.006	0.994	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.006	0.994	0.000
T40.8 Lysergide [LSD]	0.006	0.994	0.000
T40.7 Cannabis (derivatives)	0.006	0.994	0.000
T40.0 Opium	0.006	0.994	0.000
F70 Mild mental retardation	0.006	0.994	0.000
F84.5 Asperger's syndrome	0.006	0.994	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.000	0.994	0.006
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.006	0.994	0.000
F05.8 Other delirium	0.006	0.994	0.000
M70.2 Olecranon bursitis	0.006	0.994	0.000
F78 Other mental retardation	0.005	0.994	0.000
F73 Profound mental retardation	0.005	0.994	0.000
F72 Severe mental retardation	0.005	0.994	0.000
F71 Moderate mental retardation	0.005	0.994	0.000
I71.0 Dissection of aorta [any part]	0.000	0.994	0.006
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]	0.005	0.994	0.000
F84.0 Childhood autism	0.006	0.994	0.000
O00.1 Tubal pregnancy	0.006	0.994	0.000
E84 Cystic fibrosis	0.000	0.994	0.006
F99 Mental disorder, not otherwise specified	0.006	0.994	0.000
F25.9 Schizoaffective disorder, unspecified	0.005	0.994	0.000
M70.6 Trochanteric bursitis	0.005	0.994	0.000
T40.3 Methadone	0.005	0.994	0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.005	0.994	0.000
K76.6 Portal hypertension	0.000	0.994	0.006
F95.9 Tic disorder, unspecified	0.005	0.995	0.000
F95.8 Other tic disorders	0.005	0.995	0.000
F95.1 Chronic motor or vocal tic disorder	0.005	0.995	0.000
F95.0 Transient tic disorder	0.005	0.995	0.000
I61.4 Intracerebral haemorrhage in cerebellum	0.005	0.995	0.000
I61.6 Intracerebral haemorrhage, multiple localised	0.005	0.995	0.000
F84.9 Pervasive developmental disorder, unspecified	0.005	0.995	0.000
F84.8 Other pervasive developmental disorders	0.005	0.995	0.000
F84.4 Overactive disorder associated with mental retardation and stereotyped movements	0.005	0.995	0.000
F84.3 Other childhood disintegrative disorder	0.005	0.995	0.000
F84.2 Rett's syndrome	0.005	0.995	0.000
F84.1 Atypical autism	0.005	0.995	0.000
M79.06 Rheumatism, unspecified (Lower leg)	0.005	0.995	0.000
M79.01 Rheumatism, unspecified (Shoulder region)	0.005	0.995	0.000
D23.7 Skin of lower limb, including hip	0.005	0.995	0.000
F05.1 Delirium superimposed on dementia	0.005	0.995	0.000
G30.9 Alzheimer's disease, unspecified	0.005	0.995	0.000
F02.8 Dementia in other specified diseases classified elsewhere	0.005	0.995	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.005	0.995	0.000
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.005	0.995	0.000
M79.07 Rheumatism, unspecified (Ankle and foot)	0.005	0.995	0.000
F02.4 Dementia in human immunodeficiency virus [HIV] disease	0.005	0.995	0.000
F02.2 Dementia in Huntington's disease	0.005	0.995	0.000
F02.1 Dementia in Creutzfeldt-Jakob disease	0.005	0.995	0.000
E85 Amyloidosis	0.000	0.995	0.005
D36.1 Peripheral nerves and autonomic nervous system	0.005	0.995	0.000
F05.0 Delirium not superimposed on dementia, so described	0.005	0.995	0.000
F79 Unspecified mental retardation	0.005	0.995	0.000
E77 Disorders of glycoprotein metabolism	0.000	0.995	0.005
F80.1 Expressive language disorder	0.005	0.995	0.000
M70 Soft tissue disorders related to use, overuse and pressure	0.005	0.995	0.000
E75.2 Other sphingolipidosis	0.000	0.995	0.005
F02.3 Dementia in Parkinson's disease	0.005	0.995	0.000
E76 Disorders of glycosaminoglycan metabolism	0.000	0.995	0.005
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.000	0.995	0.005
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.000	0.995	0.005
E72 Other disorders of amino-acid metabolism	0.000	0.995	0.005
F80.9 Developmental disorder of speech and language, unspecified	0.005	0.995	0.000
F80.8 Other developmental disorders of speech and language	0.005	0.995	0.000
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]	0.005	0.995	0.000
F80.0 Specific speech articulation disorder	0.005	0.995	0.000
F80.2 Receptive language disorder	0.005	0.995	0.000
F90.9 Hyperkinetic disorder, unspecified	0.005	0.995	0.000
F90.8 Other hyperkinetic disorders	0.005	0.995	0.000
F90.1 Hyperkinetic conduct disorder	0.005	0.995	0.000
F90.0 Disturbance of activity and attention	0.005	0.995	0.000
F91.9 Conduct disorder, unspecified	0.005	0.995	0.000
F91.8 Other conduct disorders	0.005	0.995	0.000
F91.3 Oppositional defiant disorder	0.005	0.995	0.000
F91.2 Socialised conduct disorder	0.005	0.995	0.000
F91.1 Unsocialised conduct disorder	0.005	0.995	0.000
F91.0 Conduct disorder confined to the family context	0.005	0.995	0.000
F92.9 Mixed disorder of conduct and emotions, unspecified	0.005	0.995	0.000
F92.8 Other mixed disorders of conduct and emotions	0.005	0.995	0.000
F92.0 Depressive conduct disorder	0.005	0.995	0.000
F93.9 Childhood emotional disorder, unspecified	0.005	0.995	0.000
F93.8 Other childhood emotional disorders	0.005	0.995	0.000
F93.3 Sibling rivalry disorder	0.005	0.995	0.000
F93.2 Social anxiety disorder of childhood	0.005	0.995	0.000
F93.1 Phobic anxiety disorder of childhood	0.005	0.995	0.000
F93.0 Separation anxiety disorder of childhood	0.005	0.995	0.000
F94.9 Childhood disorder of social functioning, unspecified	0.005	0.995	0.000
F94.8 Other childhood disorders of social functioning	0.005	0.995	0.000
F94.2 Disinhibited attachment disorder of childhood	0.005	0.995	0.000
F94.1 Reactive attachment disorder of childhood	0.005	0.995	0.000
F94.0 Elective mutism	0.005	0.995	0.000
I61.8 Other intracerebral haemorrhage	0.005	0.995	0.000
F98.9 Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.005	0.995	0.000
F98.8 Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.005	0.995	0.000
F98.6 Cluttering	0.005	0.995	0.000
F98.4 Stereotyped movement disorders	0.005	0.995	0.000
F98.3 Pica of infancy and childhood	0.005	0.995	0.000
F98.2 Feeding disorder of infancy and childhood	0.005	0.995	0.000
F98.1 Nonorganic encopresis	0.005	0.995	0.000
F98.0 Nonorganic enuresis	0.005	0.995	0.000
F98.5 Stuttering [stammering]	0.005	0.995	0.000
E84.9 Cystic fibrosis, unspecified	0.000	0.995	0.005
T40.4 Other synthetic narcotics	0.005	0.995	0.000
E79 Disorders of purine and pyrimidine metabolism	0.000	0.995	0.005
T40.6 Other and unspecified narcotics	0.005	0.995	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.000	0.995	0.005
F01.8 Other vascular dementia	0.005	0.995	0.000
F01.3 Mixed cortical and subcortical vascular dementia	0.005	0.995	0.000
F01.2 Subcortical vascular dementia	0.005	0.995	0.000
F01.0 Vascular dementia of acute onset	0.005	0.995	0.000
F02.0 Dementia in Pick's disease	0.005	0.995	0.000
E70 Disorders of aromatic amino-acid metabolism	0.000	0.995	0.005
M79.05 Rheumatism, unspecified (Pelvic region and thigh)	0.005	0.995	0.000
M79.04 Rheumatism, unspecified (Hand)	0.005	0.995	0.000
M79.03 Rheumatism, unspecified (Forearm)	0.005	0.995	0.000
M79.02 Rheumatism, unspecified (Upper arm)	0.005	0.995	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.004	0.995	0.001
F01.1 Multi-infarct dementia	0.005	0.995	0.000
S92.20 Fracture of other tarsal bone(s) (closed)	0.000	0.995	0.005
F81.8 Other developmental disorders of scholastic skills	0.005	0.995	0.000
F81.3 Mixed disorder of scholastic skills	0.005	0.995	0.000
F81.2 Specific disorder of arithmetical skills	0.005	0.995	0.000
F81.1 Specific spelling disorder	0.005	0.995	0.000
F81.0 Specific reading disorder	0.005	0.995	0.000
S51.7 Multiple open wounds of forearm	0.000	0.995	0.005
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.005	0.995	0.000
T36.0 Penicillins	0.004	0.995	0.001
E75.5 Other lipid storage disorders	0.000	0.995	0.005
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.004	0.995	0.000
F70.9 Mild mental retardation (Without mention of impairment of behaviour)	0.004	0.995	0.000
O00.9 Ectopic pregnancy, unspecified	0.005	0.995	0.000
F06.6 Organic emotionally labile [asthenic] disorder	0.004	0.995	0.000
F06.5 Organic dissociative disorder	0.004	0.995	0.000
F06.4 Organic anxiety disorder	0.004	0.995	0.000
F06.1 Organic catatonic disorder	0.004	0.995	0.000
F06.0 Organic hallucinosis	0.004	0.995	0.000
O00 Ectopic pregnancy	0.005	0.995	0.000
F06.3 Organic mood [affective] disorders	0.004	0.995	0.000
F06.2 Organic delusional [schizophrenia-like] disorder	0.004	0.995	0.000
F81.9 Developmental disorder of scholastic skills, unspecified	0.004	0.995	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.004	0.995	0.000
F70.8 Mild mental retardation (Other impairments of behaviour)	0.004	0.996	0.000
F70.1 Mild mental retardation (Significant impairment of behaviour requiring attention or treatment)	0.004	0.996	0.000
F70.0 Mild mental retardation (With the statement of no, or minimal, impairment of behaviour)	0.004	0.996	0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.004	0.996	0.000
E75.6 Lipid storage disorder, unspecified	0.000	0.996	0.004
E75.4 Neuronal ceroid lipofuscinosis	0.000	0.996	0.004
E75.3 Sphingolipidosis, unspecified	0.000	0.996	0.004
E75.1 Other gangliosidosis	0.000	0.996	0.004
E75.0 GM2 gangliosidosis	0.000	0.996	0.004
R82 Other abnormal findings in urine	0.004	0.996	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.000	0.996	0.004
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.004	0.996	0.000
G30 Alzheimer's disease	0.004	0.996	0.000
E85.9 Amyloidosis, unspecified	0.000	0.996	0.004
M70.29 Olecranon bursitis-Site unspec	0.004	0.996	0.000
M70.28 Olecranon bursitis-Other	0.004	0.996	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations